Cabaletta Bio Company Insiders
CABA Stock | USD 1.78 0.11 6.59% |
About 89 percent of Cabaletta Bio's insiders are activelly selling. The analysis of the overall insider sentiment regarding Cabaletta Bio suggests that a very large number of insiders are panicking. Cabaletta Bio employs about 154 people. The company is managed by 11 executives with a total tenure of roughly 360 years, averaging almost 32.0 years of service per executive, having 14.0 employees per reported executive.
Insider Sentiment 11
Mostly Selling
Selling | Buying |
Latest Trades
2024-01-19 | Gwendolyn Binder | Disposed 11000 @ 19.59 | View | ||
2023-12-19 | Gwendolyn Binder | Disposed 11000 @ 21.89 | View | ||
2023-10-19 | Gwendolyn Binder | Disposed 11000 @ 13.36 | View | ||
2023-09-19 | Gwendolyn Binder | Disposed 11000 @ 17.57 | View | ||
2023-08-21 | Gwendolyn Binder | Disposed 11000 @ 13.42 | View | ||
2023-07-19 | Gwendolyn Binder | Disposed 11000 @ 13.82 | View | ||
2023-06-20 | Gwendolyn Binder | Disposed 11000 @ 12.99 | View | ||
2023-05-19 | Gwendolyn Binder | Disposed 22000 @ 11.81 | View | ||
2022-10-18 | Gwendolyn Binder | Acquired 20000 @ 0.99 | View |
Monitoring Cabaletta Bio's insider sentiment can offer insights into its future performance, as insiders often have access to more information about their company's operations, financial health, and upcoming initiatives than the general public. However, it's essential to note that insider trading is regulated by securities laws, and insiders are required to disclose their trades publicly to ensure transparency and prevent unfair advantages based on non-public information.
Cabaletta |
Cabaletta Bio Management Team Effectiveness
The company has return on total asset (ROA) of (0.379) % which means that it has lost $0.379 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (0.6216) %, meaning that it created substantial loss on money invested by shareholders. Cabaletta Bio's management efficiency ratios could be used to measure how well Cabaletta Bio manages its routine affairs as well as how well it operates its assets and liabilities. As of March 20, 2025, Return On Tangible Assets is expected to decline to -0.32. The current year's Return On Capital Employed is expected to grow to -0.34. At present, Cabaletta Bio's Total Assets are projected to increase significantly based on the last few years of reporting. The current year's Non Current Assets Total is expected to grow to about 11.1 M, whereas Net Tangible Assets are forecasted to decline to about 84 M.As of March 20, 2025, Common Stock Shares Outstanding is expected to decline to about 28.3 M. The current year's Net Loss is expected to grow to about (45.3 M)
Cabaletta Bio Workforce Comparison
Cabaletta Bio is rated below average in number of employees category among its peers. The total workforce of Health Care industry is currently estimated at about 2,506. Cabaletta Bio holds roughly 154 in number of employees claiming about 6% of equities under Health Care industry.
Cabaletta Bio Insider Trading
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Cabaletta Bio insiders, such as employees or executives, is commonly permitted as long as it does not rely on Cabaletta Bio's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases, Cabaletta Bio insiders must file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
Cabaletta Bio Notable Stakeholders
A Cabaletta Bio stakeholder refers to an individual interested in an outcome of the business. Different stakeholders have different interests, and companies such as Cabaletta Bio often face trade-offs trying to please all of them. Cabaletta Bio's stakeholders can have a positive or negative influence on the entity's direction, and there are a lot of executives involved in getting Cabaletta Bio's stock to the level that pleases all shareholders. Keeping track of the stakeholders is a great way to stay on top of things affecting its ongoing price.
Gwendolyn Binder | President Technology | Profile | |
Samik MD | Chief Officer | Profile | |
Steven MD | Chairman, CoFounder | Profile | |
FACR MD | Chief Officer | Profile | |
Michael JD | General Secretary | Profile | |
Heather MSc | Chief Officer | Profile | |
Qing Yuan | Chief Officer | Profile | |
Aimee MD | CoFounder Board | Profile | |
Arun MD | Chief Officer | Profile | |
Anup MBA | Chief Officer | Profile | |
Martha OConnor | Chief Officer | Profile |
About Cabaletta Bio Management Performance
The success or failure of an entity such as Cabaletta Bio often depends on how effective the management is. Cabaletta Bio management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of Cabaletta management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the Cabaletta management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.
Last Reported | Projected for Next Year | ||
Return On Tangible Assets | (0.31) | (0.32) | |
Return On Capital Employed | (0.36) | (0.34) | |
Return On Assets | (0.31) | (0.32) | |
Return On Equity | (0.33) | (0.31) |
Please note, the presentation of Cabaletta Bio's financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Cabaletta Bio's management is honest, while the outside auditors are strict and uncompromising. Please utilize our Beneish M Score to check the likelihood of Cabaletta Bio's management manipulating its earnings.
Cabaletta Bio Workforce Analysis
Traditionally, organizations such as Cabaletta Bio use manpower efficiency calculations for various incentive schemes, employee appraisal, or as an initiative to improve the processes. However, it can also be used by investors to make long-term investment decisions. The trends in the profit per employee or revenue per employee are measured by net income or revenue divided by the current number of full-time employees over a given time interval. Because workforce needs differ across sectors, these ratios could be used to compare Cabaletta Bio within its industry.Cabaletta Bio Manpower Efficiency
Return on Cabaletta Bio Manpower
Revenue Per Employee | 0.0 | |
Revenue Per Executive | 0.0 | |
Net Loss Per Employee | 439.4K | |
Net Loss Per Executive | 6.2M | |
Working Capital Per Employee | 1.5M | |
Working Capital Per Executive | 20.8M |
Complementary Tools for Cabaletta Stock analysis
When running Cabaletta Bio's price analysis, check to measure Cabaletta Bio's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Cabaletta Bio is operating at the current time. Most of Cabaletta Bio's value examination focuses on studying past and present price action to predict the probability of Cabaletta Bio's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Cabaletta Bio's price. Additionally, you may evaluate how the addition of Cabaletta Bio to your portfolios can decrease your overall portfolio volatility.
ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
Commodity Directory Find actively traded commodities issued by global exchanges |